Sex: M
Vaccine: MNQ, MNQ
Symptoms: Arthralgia, Chest discomfort, Extra dose administered, Hypoaesthesia, Muscle tightness
Clinical narrative: the patient felt a sensation that ran all the way down the arm to just above the wrist; Extra dose administered; Extra dose administered; tightness in jaw and neck; tightness in head; tightness in shoulder; The patient feels tightness in the front of the shoulder which extends to the chest area; Tingling in jaw, head and neck; Numbness in his jaw, left side of his head and neck; The patient's left wrist hurts when he bends it; This non-serious case was reported by a consumer via call center representative and described the occurrence of abnormal sensation of limbs in a 52-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 3CB9L, expiry date 30-NOV-2024) for prophylaxis.   Co-suspect products included Men ACWY-CRM NVS (Menveo) for prophylaxis.   Previously administered products included Menveo with an associated reaction of no adverse event (received previously on an unknown date 11 years ago, without any issues).   On 17-MAY-2024 09:30, the patient received Menveo (left arm). On an unknown date, the patient received Menveo. In MAY-2024, an unknown time after receiving Menveo and not applicable after receiving Menveo, the patient experienced abnormal sensation of limbs (Verbatim: the patient felt a sensation that ran all the way down the arm to just above the wrist), tightness in jaw (Verbatim: tightness in jaw and neck), head tightness (Verbatim: tightness in head), shoulder muscle stiffness (Verbatim: tightness in shoulder), chest tightness (Verbatim: The patient feels tightness in the front of the shoulder which extends to the chest area), tingling (Verbatim: Tingling in jaw, head and neck), numbness (Verbatim: Numbness in his jaw, left side of his head and neck) and wrist pain (Verbatim: The patient's left wrist hurts when he bends it). On 17-MAY-2024, the patient experienced extra dose administered (Verbatim: Extra dose administered). On an unknown date, the patient experienced extra dose administered (Verbatim: Extra dose administered). The patient was treated with naproxen (Motrin). In MAY-2024, the outcome of the abnormal sensation of limbs was resolved. The outcome of the tightness in jaw, head tightness, shoulder muscle stiffness, chest tightness, tingling, numbness and wrist pain were not resolved and the outcome of the extra dose administered and extra dose administered were unknown.   It was unknown if the reporter considered the abnormal sensation of limbs, tightness in jaw, head tightness, shoulder muscle stiffness, chest tightness, tingling, numbness and wrist pain to be related to Menveo.  It was unknown if the company considered the abnormal sensation of limbs, tightness in jaw, head tightness, shoulder muscle stiffness, chest tightness, tingling, numbness and wrist pain to be related to Menveo.   Additional Information: GSK Receipt Date: 17-MAY-2024 The reporter was the patient. The patient stated that he received the Menveo vaccine in the left shoulder area. As soon as the needle was gone into the patient's left arm, the patient felt a sensation that ran all the way down the arm to just above the wrist. The sensation quickly went away. The patient questions if the needle hit a nerve or not. The moment the patient got home after the vaccination, the patient felt tightness, tingling, and numbness, in his jaw, and left side of his head and neck. The patient felt tightness in the front of the shoulder which extended to the chest area. The patient's left wrist hurts when he bended it. The patient called his doctor and was told to use warm compresses, which he did for a couple of hours. The patient also taken Motrin. The patient received 2 doses of Menveo on 17-MAY-2024 and 6 years ago without any issues, which led to extra dose administered. The reporter / patient did not wish to provide date of birth. The reporter/ patient did not wish to provide consent to healthcare professional (HCP) follow up at this time. However, the reporter / patient welcomes follow up from the safety department.